Bavarian Nordic A/S announced today that the European Commission has granted marketing authorization for IMVANEX for active immunization against smallpox disease for the general adult population, including people with weakened immune systems .
http://www.medilexicon.com/medicalnews.php?newsid=264586
http://www.medilexicon.com/medicalnews.php?newsid=264586
No comments:
Post a Comment